secwatch.observer — SEC 8-K summary
======================================

Issuer:     Intellia Therapeutics, Inc. (NTLA)
CIK:        0001652130
Form:       8-K
Filed at:   2026-06-10T20:36:13+00:00
Accession:  0001193125-26-265934
Event type: other
Sentiment:  neutral
Materiality: 0.10
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Intellia Therapeutics annual meeting elects three directors, ratifies auditor, passes say-on-pay
--------------------------------------------------------------------------------

- Elected Bhanji (57.1M for), Goff (46.1M), Goodman (43.0M) as Class I directors for three-year terms.
- Ratified Deloitte & Touche as auditor for FY2026 with 87.8M votes for.
- Advisory vote on executive compensation passed with 44.8M for, 13.8M against.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1652130/000119312526265934/0001193125-26-265934-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1652130/000119312526265934/ntla-20260609.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-265934

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer